These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 2206032
1. Comparison of the effects of lovastatin and gemfibrozil on lipids and glucose control in non-insulin-dependent diabetes mellitus. Goldberg R, La Belle P, Zupkis R, Ronca P. Am J Cardiol; 1990 Sep 18; 66(8):16B-21B. PubMed ID: 2206032 [Abstract] [Full Text] [Related]
4. Gemfibrozil alone and in combination with lovastatin for treatment of hypertriglyceridemia in NIDDM. Garg A, Grundy SM. Diabetes; 1989 Mar 18; 38(3):364-72. PubMed ID: 2917701 [Abstract] [Full Text] [Related]
5. A multicenter double-blind study comparing lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia. Vallés F, Anguita M, Anglada J, Aguirre C, Fabiani F, Plaza L, Soriguer F, Azanza JR, Barcina C. Atherosclerosis; 1991 Dec 18; 91 Suppl():S3-9. PubMed ID: 1789815 [Abstract] [Full Text] [Related]
6. Comparison of gemfibrozil and lovastatin in patients with high low-density lipoprotein and low high-density lipoprotein cholesterol levels. McKenney JM, Barnett MD, Wright JT, Proctor JP. Arch Intern Med; 1992 Sep 18; 152(9):1781-7. PubMed ID: 1520045 [Abstract] [Full Text] [Related]
7. Effect of gemfibrozil versus lovastatin on increased serum lipoprotein(a) levels of patients with hypercholesterolemia. Ramires JA, Mansur AP, Solimene MC, Maranhão R, Chamone D, da Luz P, Pileggi F. Int J Cardiol; 1995 Feb 18; 48(2):115-20. PubMed ID: 7774989 [Abstract] [Full Text] [Related]
8. A comparison of lovastatin, an HMG-CoA reductase inhibitor, with gemfibrozil, a fibrinic acid derivative, in the treatment of patients with diabetic dyslipidemia. Bell DS. Clin Ther; 1995 Feb 18; 17(5):901-10. PubMed ID: 8595642 [Abstract] [Full Text] [Related]
9. [Clinical trial of lovastatin versus gemfibrozil in the treatment of primary hypercholesterolemia]. Catalán M, López de Ocáriz A, Alvarez MP, Ariño M, Azanza JR, Honorato J. Rev Med Univ Navarra; 1992 Feb 18; 37(3):127-33. PubMed ID: 1480917 [Abstract] [Full Text] [Related]
11. A crossover comparison of the efficacy and safety of lovastatin and gemfibrozil in the treatment of hyperlipidemic organ transplant recipients. Hanes DS, Nicholson PG, Raval DD, Hooper FL, Behrens MT, Weir MR. Am J Ther; 1997 Feb 18; 4(2-3):85-91. PubMed ID: 10423597 [Abstract] [Full Text] [Related]
13. Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation. Zambón D, Ros E, Rodriguez-Villar C, Laguna JC, Vázquez M, Sanllehy C, Casals E, Sol JM, Hernández G. Metabolism; 1999 Jan 18; 48(1):47-54. PubMed ID: 9920144 [Abstract] [Full Text] [Related]
14. Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: the Finnish Multicenter Study. Tikkanen MJ, Helve E, Jäättelä A, Kaarsalo E, Lehtonen A, Malbecq W, Oksa H, Pääkkönen P, Salmi J, Veharanta T. Am J Cardiol; 1988 Nov 11; 62(15):35J-43J. PubMed ID: 3055922 [Abstract] [Full Text] [Related]
18. Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia. Illingworth DR, Bacon S. Circulation; 1989 Mar 11; 79(3):590-6. PubMed ID: 2645064 [Abstract] [Full Text] [Related]